Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials

V Madelain, F Mentré, S Baize… - CPT …, 2020 - Wiley Online Library
experiments and expected in the JIKI trial. Accordingly, a first … In addition to historical
preclinical data available from the … Ebola virus and treated with ascending doses of favipiravir. Left…

The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers

D Malvy, AM Taburet, X de Lamballerie… - … Tropical Diseases, 2020 - journals.plos.org
treating influenza virus infections. In the setting of the pioneer Phase II JIKI trial, 126 patients
with acute Ebola virus diseaseJIKI trial, favipiravir treatment was offered in the Coyah Ebola

Favipiravir in therapy of viral infections

R Łagocka, V Dziedziejko, P Kłos, A Pawlik - Journal of clinical medicine, 2021 - mdpi.com
… FPV was also used in the therapy of Ebola virus disease (… patient group treated with the drug
and the historical patient group … fever virus, both in cell cultures and in experimental animal …

Favipiravir, an antiviral for COVID-19?

EA Coomes, H Haghbayan - Journal of Antimicrobial …, 2020 - academic.oup.com
trial for Ebola virus disease in Guinea. In a retrospective analysis of 124 patients with Ebola
virus disease in Sierra Leone, those treated … compared with historical controls treated with …

Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates

V Madelain, A Duthey, F Mentré, F Jacquot, C Solas… - Antiviral Research, 2020 - Elsevier
… -human primate model of Ebola virus disease. In this study, … antiviral efficacy in a historically
controlled trial (JIKI trial), but our … experiments conducted in a macaque model of Ebola Virus

[HTML][HTML] Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus Disease

DM Johnson, T Juelich, L Zhang, JK Smith… - Viruses, 2024 - mdpi.com
… Another trial of favipiravir treatment of an intranasal model of EVD in interferon … During the
JIKI trial, an unexpected drop in human serum titers of … experiment. This suggests that 8 days of …

Targeting Ebola virus replication through pharmaceutical intervention

F Hansen, H Feldmann, MA Jarvis - Expert Opinion on …, 2021 - Taylor & Francis
… Small geographically isolated outbreaks have historically been … experimental therapy. In
2015, the Partnership for Research on … nonrandomized clinical trial (called the JIKI trial) was …

Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis

EH Dahl, P Mbala, S Juchet, A Touré… - The Lancet Global …, 2024 - thelancet.com
… , non-randomised trial with historical controls in which favipiravir … with confirmed Ebola virus
disease with a lower viral load (cycle … -infected patients of the JIKI trial reveals concentrations …

Therapeutics development for Ebola virus disease: a recent scenario

C Chakraborty - Current Opinion in Pharmacology, 2021 - Elsevier
… and also a single-arm, controlled trial. This clinical trial is known as the JIKI trial, which …
in the survival of patients with EVD receiving favipiravir compared with controls [19]. Another …

Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates

S Reynard, E Gloaguen, N Baillet… - … Tropical Diseases, 2021 - journals.plos.org
… events observed during Ebola virus disease are linked to a … previous experiment in which
three doses of favipiravir were … for patients treated with favipiravir during the clinical trial [53] …